Cas 252947-95-8,4-[6-(t-butyldimethylsilyloxy)-1-hexynyl]-4-hydroxy-7-methoxy-3-(4-methoxyphenyl)-3-methylthiochroman

252947-95-8

Post Buying Request

Basic information

Product Name: 4-[6-(t-butyldimethylsilyloxy)-1-hexynyl]-4-hydroxy-7-methoxy-3-(4-methoxyphenyl)-3-methylthiochroman
Synonyms: 4-[6-(t-butyldimethylsilyloxy)-1-hexynyl]-4-hydroxy-7-methoxy-3-(4-methoxyphenyl)-3-methylthiochroman
CAS NO:252947-95-8
Molecular Formula:
Molecular Weight: 526.813
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-[6-(t-butyldimethylsilyloxy)-1-hexynyl]-4-hydroxy-7-methoxy-3-(4-methoxyphenyl)-3-methylthiochroman(CAS DataBase Reference)
NIST Chemistry Reference: 4-[6-(t-butyldimethylsilyloxy)-1-hexynyl]-4-hydroxy-7-methoxy-3-(4-methoxyphenyl)-3-methylthiochroman(252947-95-8)
EPA Substance Registry System: 4-[6-(t-butyldimethylsilyloxy)-1-hexynyl]-4-hydroxy-7-methoxy-3-(4-methoxyphenyl)-3-methylthiochroman(252947-95-8)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 252947-95-8(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

252947-95-8 Suppliers

Recommended suppliers

252947-95-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 252947-95-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,2,9,4 and 7 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 252947-95:
(8*2)+(7*5)+(6*2)+(5*9)+(4*4)+(3*7)+(2*9)+(1*5)=168
168 % 10 = 8
So 252947-95-8 is a valid CAS Registry Number.

252947-95-8Upstream product

252947-95-8Downstream Products

252947-95-8Relevant academic research and scientific papers

Benzopyran or thiobenzopyran derivatives

-

Page/Page column 195, (2010/01/31)

The present invention provides novel benzopyran compounds, pharmaceutically acceptable salts thereof and stereoisomers thereof where the benzopyran compounds of the invention are compounds according to Formula I: The present invention further provides pharmaceutical compositions which possess anti-estrogenic activity and comprise at least one benzopyran compound of the invention and a method of treating breast cancer by administration of an effective amount of a benzopyran compound provided by the present invention.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 252947-95-8